Avalyn plans IPO to fund phase 3 trials of inhaled versions of approved respiratory drugs
Avalyn plans IPO to fund phase 3 trials of inhaled versions of approved respiratory drugs
Body unavailable. Use the original source.
Avalyn plans IPO to fund phase 3 trials of inhaled versions of approved respiratory drugs
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.